Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Chiron

Chiron Corporation, headquartered in Emeryville, California, is a global pharmaceutical company that leverages a diverse business model to develop and commercialize high-value products that make a difference in people's lives. The company has a strategic focus on cancer and infectious disease. Chiron applies its advanced understanding of the biology of cancer and infectious disease to develop products from its platforms in proteins, small molecules and vaccines. The company commercializes its products through three business units: vaccines, blood testing, and biopharmaceuticals.


Contact Details:
201 Elliott Ave. West, Suite 150
Seattle
Washington
98119
United States of America
Tel:206-467-8100
Fax:206-270-3313
Email:bhoskins@pathogenesis.com
WWW:

www.chiron.com/




Loading...

Recent Publications by Chiron:

Phosphorothioate-modified TLR9 ligands protect cancer cells against TRAIL-induced apoptosis.
Hypomethylated CpG oligodeoxynucleotides (CpG ODNs) target TLR9 expressed...
17th November, 2009
Institut de Recherche Therapeutique de l'Universite de Nantes, Institut J Immunol. 2009 Oct 1;183(7):4371-7. Epub 2009 Sep 4.
DOI Direct Link
Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.
BACKGROUND: Screening of blood units for hepatitis B virus (HBV) DNA...
18th August, 2009
From the Spanish Red Cross Blood Transfusion Center and the Transfusion Transfusion. 2009 Aug 4.
DOI Direct Link
[Obstetric epidural analgesia: systemic analysis of an error of syringe rate programming]
We reported an error of syringe rate programming during maintenance of...
6th August, 2009
Service d'anesthesie ambulatoire-reanimation, centre hospitalier de Blois, Ann Fr Anesth Reanim. 2009 May;28(5):489-92. Epub 2009 May 1.
DOI Direct Link
Transient occult hepatitis B virus infection in a blood donor with high viremia.
BACKGROUND: Screening of blood donors for viral nucleic acids has recently...
6th May, 2009
From the Institute of Medical Virology, Justus Liebig University, Giessen, Transfusion. 2009 Apr 24.
DOI Direct Link
Lipoxin A(4) and interleukin-8 levels in cystic fibrosis sputum after antibiotherapy.
Antibiotics are largely prescribed for cystic fibrosis (CF) respiratory...
4th March, 2009
INSERM, J Cyst Fibros. 2008 Nov;7(6):463-8. Epub 2008 Jun 9.
DOI Direct Link

View more Chiron research publications.

Press Releases on Chiron:

BioPortfolio Logo
Reportlinker Adds Blood Banking and Blood Products - Global Market Perspective 25th November, 2009 Reportlinker
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Blood Banking and Blood Products - Global Market Perspective http://www
Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results 6th August, 2009 Orexigen Therapeutics, Inc.
-- Contrave was generally well tolerated by patients across the COR Phase 3 program. The COR program data continue to be analyzed and compiled for submission to relevant
New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report 7th July, 2009 Reportlinker
NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Hepatitis C Virus And Therapeutics Market http://www.reportlinker.com/p0119497/World
Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer 9th June, 2009 Nektar Therapeutics
SAN CARLOS, Calif., June 9 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced the promotion of Lorianne Masuoka, M.D. to the position of Chief Medical Officer. Dr. Masuoka
Gen-Probe Reports Financial Results for First Quarter 2009 30th April, 2009 Gen-Probe Incorporated
Three Months Ended March 31, Change 2009 2008 Reported Constant

BioNews Results for Chiron:

Royal Caribbean takes the wraps off world's biggest cruise ship
USA Today:  Nov 20 2009 2:45PM Matching: chiron
Still plenty of cabins available for early sailings of world's largest cruise ship
USA Today:  Nov 19 2009 2:39PM Matching: chiron
Cruise Deals Abound This Winter
ABC News:  Nov 19 2009 12:49PM Matching: chiron
Single-Use Bioreactors: A Brief Review Of Current Technology
Bioresearch Online:  Nov 19 2009 9:02PM Matching: chiron
ImmunoGen Discloses Board Appointments and Results of Shareholders Meeting
TradingMarkets:  Nov 17 2009 5:30AM Matching: chiron
Promote your company here: BioNewsCast - Press Release Distribution

View more Chiron news.

Chiron Clinical Trials:

A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults

Chiron Patents:

US Patent No.Title
7135321 GSK3 polypeptides
7186407 Methods and compositions for the treatment of peripheral artery disease
7186530 Protein associated with cell stress response
7189727 Guanidino compounds
7193042 Methods for purifying authentic IGF from yeast hosts

View more Chiron patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 283 individuals from Chiron using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 284 times since April 2007, the link to the organisation's website has been followed 70 times

Recent Search Terms used to find this page: R. Chiron cnrs | .

Search for more companies in Seattle

Search for more companies in Washington



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Chiron

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.